Abstract
We describe the case of a 53-year-old Philadelphia-chromosome-positive woman with chronic myelogenous leukemia, who developed pulmonary alveolar proteinosis (PAP). The possible mechanism involved in the pathogenesis of PAP are discussed based on the clinical and laboratory data for this patient as well as on experimental and clinical data reported in the literature.
References
1.
Bedrossian CWM, Luna MA, Conklin RH: Alveolar proteinosis as a consequence of immunosuppression. Hum Pathol 1980;11:527–535.
2.
Israel RH, Magnussen CR: Are AIDS patients at risk for pulmonary alveolar proteinosis? Chest 1989;96:641–642.
3.
Prakash UBS, Barham SS, Carpenter HA: Pulmonary alveolar phospholipoproteinosis: Experience with 34 cases and a review. Mayo Clin Proc 1987;62:499–518.
4.
Rosen Sh, Castleman B, Liebow AA: Pulmonary alveolar proteinosis. N Engl J Med 1958;258:1123–1142.
5.
Aymard JP, Gyger M, Lavalle R, Legresley LP, Desy M: A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. Cancer 1984;53:954–956.
6.
Cordonnier C, Fleury-Feith J, Escudier E, Attssi K, Bernaudin JF: Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149:788–794.
7.
Fres AO, Cohn ZA: The alveolar macrophage (review) (212 refs). J Appl Physiol 1986;60:353–369.
8.
Golde DW, Territo M, Finley TN, Cline MJ: Defective lung macrophage in pulmonary alveolar proteinosis. Ann Intern Med 1976;85:304–309.
9.
Nugent KM, Pasanti EL: Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis 1983;127:780–781.
10.
Hoffmann RM, Dauber JH, Rogers RM: Improvement in alveolar macrophage migration after therapeutic whole lung lavage in pulmonary alveolar proteinosis. Am Rev Respir Dis 1989;139:1030–1032.
11.
Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC: Involvement of granulocyte macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994;264:713–715.
12.
Green D, Dighe P, Ali NO, Katele GV: Pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. Cancer 1980;46:1763–1766.
13.
Wilson DO, Roger RM: Prolonged spontaneous remission in a patient with untreated pulmonary alveolar proteinosis. Am J Med 1987;82:1914–1916.
14.
Rinehalt JJ, Sagone AL, Balcerzak P, Ackerman GA, Lobuglio AF: Effects of corticosteroid therapy on human monocyte function. N Engl J Med 1975;292:236–241.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
